EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance

Lotte Stegat, Alicia Eckhardt, Antonia Gocke, Sina Neyazi, Lara Pohl, Simone Schmid, Matthias Dottermusch, Stephan Frank, Hans Pinnschmidt, Jochen Herms, Markus Glatzel, Matija Snuderl und 6 weitere

Acta Neuropathologica · 10.09.2024 · 148 (1)

DOI: 10.1007/s00401-024-02800-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 10.09.2024. Verfasst von Lotte Stegat und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Glioma, DNA Methylation, Mutation, Histones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubertus-Wald Stiftung, Mildred Scheel Cancer Career Center Hamburg/Deutsche Krebshilfe, Fördergemeinschaft Kinderkrebs-Zentrum Hamburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

H3 K27M-altered diffuse midline gliomas (DMGs) are highly malignant tumours that arise in the midline structures of the CNS. Most DMGs carry an H3 K27M-mutation in one of the genes encoding for histone H3. Recent studies suggested that epigenetic subgroups of DMGs can be distinguished based on alterations in the MAPK-signalling pathway, tumour localisation, mutant H3-gene, or overall survival (OS). However, as these parameters were studied individually, it is unclear how they collectively influence survival. Hence, we analysed dependencies between different parameters, to define novel epigenetic, clinically meaningful subgroups of DMGs. We collected a multifaceted cohort of 149 H3 K27M-mutant DMGs, also incorporating data of published cases. DMGs were included in the study if they could be clearly allocated to the spinal cord ( n = 31; one patient with an additional sellar tumour), medulla ( n = 20), pons ( n = 64) or thalamus ( n = 33), irrespective of further known characteristics. We then performed global genome-wide DNA methylation profiling and, for a subset, DNA sequencing and survival analyses. Unsupervised hierarchical clustering of DNA methylation data indicated two clusters of DMGs, i.e. subtypes DMG-A and DMG-B. These subtypes differed in mutational spectrum, tumour localisation, age at diagnosis and overall survival. DMG-A was enriched for DMGs with MAPK-mutations , medullary localisation and adult age. 13% of DMG-A had a methylated MGMT promoter. Contrarily, DMG-B was enriched for cases with TP53 -mutations, PDGFRA -amplifications, pontine localisation and paediatric patients. In univariate analyses, the features enriched in DMG-B were associated with a poorer survival. However, all significant parameters tested were dependent on the cluster attribution, which had the largest effect on survival: DMG-A had a significantly better survival compared to DMG-B ( p < 0.001). Hence, the subtype attribution based on two methylation clusters can be used to predict survival as it integrates different molecular and clinical parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaDNA MethylationMutationHistonesBrain NeoplasmsHumansMaleFemalePrognosisAdultAdolescentChildYoung AdultChild, PreschoolMiddle AgedInfantDNA Modification MethylasesTumor Suppressor ProteinsCohort StudiesAgedDNA Repair Enzymes

Stichwörter der Autor:innen

DNA methylation analysesDiffuse midline gliomaMutationsSurvival

Substanzen

HistonesDNA Modification MethylasesTumor Suppressor ProteinsMGMT protein, humanDNA Repair Enzymes

Autor:innen und Institutionen

  • Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Research Institute Children's Cancer Center Hamburg, Martinistrasse 52, N63 (HPI), 20251, Hamburg, Germany.
  • Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Section of Mass Spectrometric Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

ORCID-Profile: Annika K Wefers

Förderung

  • Hubertus-Wald Stiftung
  • Mildred Scheel Cancer Career Center Hamburg/Deutsche Krebshilfe
  • Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Stegat, L., Eckhardt, A., Gocke, A., Neyazi, S., Pohl, L., Schmid, S., Dottermusch, M., Frank, S., Pinnschmidt, H., Herms, J., Glatzel, M., Snuderl, M., Schweizer, L., Thomas, C., Neumann, J., Dorostkar, M. M., Schüller, U., & Wefers, A. K. (2024). Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02800-3

Vancouver

Stegat L, Eckhardt A, Gocke A, Neyazi S, Pohl L, Schmid S, et al. Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance. Acta Neuropathologica. 2024;148(1). doi:10.1007/s00401-024-02800-3

BibTeX
@article{Stegat2024,
  author = {Stegat, Lotte and Eckhardt, Alicia and Gocke, Antonia and Neyazi, Sina and Pohl, Lara and Schmid, Simone and Dottermusch, Matthias and Frank, Stephan and Pinnschmidt, Hans and Herms, Jochen and Glatzel, Markus and Snuderl, Matija and Schweizer, Leonille and Thomas, Christian and Neumann, Julia and Dorostkar, Mario M and Schüller, Ulrich and Wefers, Annika K},
  title = {Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance},
  journal = {Acta Neuropathologica},
  year = {2024},
  volume = {148},
  number = {1},
  doi = {10.1007/s00401-024-02800-3}
}
Kostenlos starten →